Advertisement
Organisation › Details
Themis Bioscience N.V.
Themis Bioscience GmbH develops prophylactic vaccines from the preclinical to the early clinical phase, focusing on infectious diseases, with initial vaccine candidates currently being developed against Chikungunya and Zika. The company's highly innovative and fully patent-protected virus vaccine vector technology platform, licensed from the internationally respected Institut Pasteur in Paris, forms the basis for the current vaccine candidates of the Vienna-based company. *
Start | 2009-09-01 established | |
Group | Merck (US) (MSD) (Group) | |
Industry | vaccine | |
Person | Tauber, Erich (Themis Bioscience GmbH 201505 CEO) | |
Region | Amsterdam | |
Country | Netherlands | |
City | n. a. Amsterdam | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | B: 11 to 50 (2018-10-29) |
Currency | EUR | |
Annual sales | 2,567,000 (income, operating, other, consolidated (2017) 2017-12-31) | |
Profit | -4,865,000 (2017-12-31) | |
Cash | 5,178,000 (2018-06-30) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Merck (US) (MSD) (Group)
- [1] Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA....
- [2] AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal....
- [3] Anavo Therapeutics B.V.. (5/2/23). "Press Release: Anavo Therapeutics Extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic". Leiden & Heidelberg....
- [4] Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna....
- [5] Novartis AG. (9/1/22). "Press Release: Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., Steps Down from the Executive Committee of Novartis". Basel....
- [6] Catalym GmbH. (5/4/21). "Press Release: Catalym Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer". Munich....
- [7] F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna....
- [8] CRISPR Therapeutics AG. (2/1/21). "Press Release: CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer". Zug & Cambridge, MA....
- [9] Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren....
- [10] Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top